Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine.
about
Cancer as a metabolic diseaseClinical and experimental applications of sodium phenylbutyrateAmmonia toxicity and its prevention in inherited defects of the urea cyclePhenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cellsElevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors.Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors.First example of hepatocyte transplantation to alleviate ornithine transcarbamylase deficiency, monitored by NMR-based metabonomics.Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humans.
P2860
Q21245061-0C3A277B-B521-49F0-82BC-D02C084463F7Q24613511-95258334-7145-446E-BC1E-8446007366EFQ28248702-670A8A5C-9EB9-49FC-8C42-E3BB0762FD4FQ28360372-A9EE7971-775C-4B4F-B1F1-DB1A54C37794Q33939797-79198B1E-0EDB-47C5-B29B-515093F532CEQ34091001-489985E3-1AE4-4286-9977-1660D174732BQ34983962-4ABC14CA-27A1-49BE-A08C-A5A46869E992Q40277377-7DEA61D6-A2F7-4D86-B795-B4C24FEB0F75Q42807274-9FB53AAB-0E23-40D7-BED1-360582F43A56Q44060683-D5A716AC-68D5-4E59-8593-60CBFB08A172
P2860
Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Disposition of phenylbutyrate ...... ate and phenylacetylglutamine.
@en
Disposition of phenylbutyrate ...... ate and phenylacetylglutamine.
@nl
type
label
Disposition of phenylbutyrate ...... ate and phenylacetylglutamine.
@en
Disposition of phenylbutyrate ...... ate and phenylacetylglutamine.
@nl
prefLabel
Disposition of phenylbutyrate ...... ate and phenylacetylglutamine.
@en
Disposition of phenylbutyrate ...... ate and phenylacetylglutamine.
@nl
P2093
P2860
P1476
Disposition of phenylbutyrate ...... ate and phenylacetylglutamine.
@en
P2093
A Thibault
A Tompkins
R Lieberman
S C Piscitelli
P2860
P304
P356
10.1002/J.1552-4604.1995.TB04075.X
P577
1995-04-01T00:00:00Z